The United States is experiencing its highest number of measles cases in decades amid declining vaccination rates. Researchers have begun developing treatments for the virus and for vulnerable individuals.
Up until recently, the effectiveness of measles vaccination meant there was little medical or financial incentive to create treatments for the disease.
As cases climb, scientists are now working on drugs to assist those who become infected or face higher risks from the virus.
The shift reflects changing public health conditions in the country.
